Exacerbation and remission of pulmonary micronodules with lymphangioleiomyomatosis around the time of childbirth

Ogawa, Ryo; Miyagawa, Masao; Ide, Kana; Akamune, Akihisa; Ohtsuki, Yuji; Mochizuki, Takashi

doi:10.1007/s11604-013-0221-9

Cited by 3 publications

(3 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The remaining 25 (81%) of studies were case reports that included one patient each. Of the 31 studies included, 9 (29%) were published in the United States, 14,15,[17][18][19][20][21][22][23] 7 (23%) in the United Kingdom, 9,18,24-28 6 (19%) in Japan, 16,[29][30][31][32][33] and 1 from each of the following countries: Germany, 34 Ireland, 35 Iran, 36 Scotland, 37 Australia, 38 India, 39 Israel, 40 Italy, 41 and Canada. 4 Regarding risk of bias among the 7 cohort studies, 2 studies (33%) received <5 points, while 5 studies (67%) received !5 points, indicating the majority of cohort studies had a low risk of bias.…”

Section: Resultsmentioning

confidence: 99%

“…Exacerbation and remission of pulmonary micronodules with lymphangioleiomyomatosis around time of childbirth 32 ( Japanese Journal of Radiology )…”

Section: Resultsmentioning

confidence: 99%

“…The remaining 25 (81%) of studies were case reports that included one patient each. Of the 31 studies included, 9 (29%) were published in the United States, 14 15 17 18 19 20 21 22 23 7 (23%) in the United Kingdom, 9 18 24 25 26 27 28 6 (19%) in Japan, 16 29 30 31 32 33 and 1 from each of the following countries: Germany, 34 Ireland, 35 Iran, 36 Scotland, 37 Australia, 38 India, 39 Israel, 40 Italy, 41 and Canada. 4…”

Section: Resultsmentioning

confidence: 99%

See 2 more Smart Citations

Systematic Review of Lymphangioleiomyomatosis Outcomes in Pregnancy and a Proposed Management Guideline

et al. 2023

View full text Add to dashboard Cite

Background: Lymphangioleiomyomatosis (LAM) is a rare, multisystem disease that primarily affects women of reproductive age. Disease progression has been linked to estrogen exposure, and as such many patients are advised to avoid pregnancy. Data are limited regarding the interaction between LAM and pregnancy, and as such we performed a systematic review to summarize available literature reporting outcomes of pregnancies complicated by maternal LAM. Study Design: This was a systematic review including randomized controlled trials, observational studies, systematic reviews, case reports, clinical practice guidelines, and quality improvement studies with full text manuscripts or abstracts in the English language with primary data on pregnant or postpartum patients with LAM. The primary outcome was maternal outcomes during pregnancy as well as pregnancy outcomes. Secondary outcomes were neonatal outcomes and long-term maternal outcomes. This search occurred in June 2020 and included MEDLINE, Scopus, clinicaltrials.gov, Embase, and Cochrane Central. Risk of bias was ascertained using the Newcastle-Ottawa Scale. Our systematic review was registered with PROSPERO as protocol number CRD 42020191402. Results: 175 publications were identified in our initial search; ultimately 31 studies were included. Six (19%) studies were retrospective cohort studies and twenty-five (81%) studies were case reports. Patients diagnosed during pregnancy had worse pregnancy outcomes compared to those diagnosed with LAM prior to pregnancy. Multiple studies reported a significant risk of pneumothoraces during pregnancy. Other significant risks included preterm delivery, chythoraces, and pulmonary function deterioration. A proposed strategy for preconception counseling and antenatal management is provided. Conclusion: Patients diagnosed with LAM during pregnancy generally experience worse outcomes including recurrent pneumothoraces and preterm delivery as compared to patients with a LAM diagnosis prior to pregnancy. Further investigation of the interaction between LAM and pregnancy is warranted to guide patient care and counseling.

show abstract

Section: Resultsmentioning

confidence: 99%

“…Exacerbation and remission of pulmonary micronodules with lymphangioleiomyomatosis around time of childbirth 32 ( Japanese Journal of Radiology )…”

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Systematic Review of Lymphangioleiomyomatosis Outcomes in Pregnancy and a Proposed Management Guideline

et al. 2023

View full text Add to dashboard Cite

show abstract

Renal Angiomyolipoma in Pregnancy: a Case Report and Systematic Review

Soerensen

Nielsen

Madsen

2022

SN Compr. Clin. Med.

View full text Add to dashboard Cite

The effect of pregnancy on renal angiomyolipoma; a world of knowledge to gain, specifically in women with TSC

Kluiving,

Peeters,

Lely

et al. 2024

BMC Nephrol

View full text Add to dashboard Cite

Background Women are counseled preconceptionally about the potential risks of rAML progression and chance of complications during and due to pregnancy. However, a systematic search investigating the evidence on which this advice is based does not exist. The aim of this systematic review is to determine the effect of pregnancy on renal angiomyolipoma (rAML) size and risk of haemorrhage in patients with tuberous sclerosis complex (TSC). Methods We searched PubMed, EMBASE, Medline and ClinicalTrials.gov using terms for “renal angiomyolipoma” and “pregnancy”. English-language articles published between January 1st 2000, and December 31st 2020 of which full-text was available were included. The initial search resulted in 176 articles. After the screening process we included 45 case reports and 1 retrospective study. For the retrospective study we assessed the risk of bias using the Newcastle–Ottawa Scale. We included articles about renal AML and pregnancy with and without an established diagnosis of TSC. From these articles we recorded the rAML sizes and rAML complications. Results Seven case reports, from a total of 45 case reports, provided follow-up data on renal AML size (these were all cases of renal AML without a known diagnosis of TSC). Of these cases, renal AML size decreased in one patient, was stable in one patient, increased in three patients and fluctuated in two others. Renal AML size of women who suffered a haemorrhage were significantly larger (12.1 ± 4.6 cm) than rAMLs of women who did not suffer a haemorrhage (8.3 ± 3.2 cm). Data from the retrospective study showed no difference in renal complications between the women with and without a history of pregnancy. Haemorrhage occurred in 30% of the women with a history of pregnancy (n = 20) and in 11% in the patients without a history of pregnancy (n = 2), however this retrospective study had methodological limitations. Conclusion The effect of pregnancy on renal AML size and complications in patients with TSC is unclear. More research is needed to determine the risk of pregnancy on TSC-associated kidney disease in TSC patient.

show abstract

Exacerbation and remission of pulmonary micronodules with lymphangioleiomyomatosis around the time of childbirth

Cited by 3 publications

References 9 publications

Systematic Review of Lymphangioleiomyomatosis Outcomes in Pregnancy and a Proposed Management Guideline

Systematic Review of Lymphangioleiomyomatosis Outcomes in Pregnancy and a Proposed Management Guideline

Renal Angiomyolipoma in Pregnancy: a Case Report and Systematic Review

The effect of pregnancy on renal angiomyolipoma; a world of knowledge to gain, specifically in women with TSC

Contact Info

Product

Resources

About